Familial Risks for Type 2 Diabetes in Sweden

OBJECTIVE Our aim was to characterize familial risks for type 2 diabetes by the type and number of affected family members, including half-siblings, adoptees, and spouses, to quantify risks and estimate the contribution of environmental effect. RESEARCH DESIGN AND METHODS Families were identified from the Multigeneration Register, and type 2 diabetic patients were obtained from the Hospital Discharge Register. Standardized incidence ratios were calculated for offspring with type 2 diabetes whose family members were hospitalized for type 2 diabetes at ages >39 years compared with those lacking affected family members. RESULTS The number of hospitalized type 2 diabetic patients was 157,549. Among 27,895 offspring, 27.9% had a parent or sibling also hospitalized for type 2 diabetes. The familial relative risk (RR) ranged from 2.0 to >30, depending on the number and type of probands. The highest RRs of type 2 diabetes were found in individuals who had at least two siblings affected by type 2 diabetes, irrespective of the parental disease. Adoptees showed no risk from adopted parents. CONCLUSIONS The study, the largest yet published, showed that familial RRs varied by the number and type of affected family member. However, much of the familial clustering remains yet to be genetically explained. The high risk should be recognized in clinical genetic counseling. The data from adoptees confirmed the genetic basis of the familial associations, but those from half siblings and spouses suggested that a smaller part of familial clustering may be accounted for by environmental factors.

[1]  Leif Groop,et al.  Genetic dissection of type 2 diabetes , 2009, Molecular and Cellular Endocrinology.

[2]  K. Narayan,et al.  Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.

[3]  Mark I. McCarthy,et al.  Assessing the Combined Impact of 18 Common Genetic Variants of Modest Effect Sizes on Type 2 Diabetes Risk , 2008, Diabetes.

[4]  Cornelia M van Duijn,et al.  Genome-based prediction of common diseases: advances and prospects. , 2008, Human molecular genetics.

[5]  M. Martinell,et al.  Prevalence and incidence of Type 2 diabetes and its complications 1996–2003—estimates from a Swedish population‐based study , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[6]  M. Patti,et al.  The emerging genetic architecture of type 2 diabetes. , 2008, Cell metabolism.

[7]  M. Martinell,et al.  Resource use and costs of type 2 diabetes in Sweden – estimates from population‐based register data , 2008, International journal of clinical practice.

[8]  P. Froguel,et al.  Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. , 2008, Endocrine reviews.

[9]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[10]  K. Midthjell,et al.  Influence of Family History of Diabetes on Incidence and Prevalence of Latent Autoimmune Diabetes of the Adult , 2007, Diabetes Care.

[11]  L. Cannon-Albright,et al.  Familiality of diabetes mellitus. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[12]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[13]  R Williams,et al.  Prevention of type 2 diabetes: a review. , 2007, Diabetes research and clinical practice.

[14]  K. Hemminki,et al.  Constraints for genetic association studies imposed by attributable fraction and familial risk. , 2006, Carcinogenesis.

[15]  K. Hemminki,et al.  The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence , 2006, Hereditary cancer in clinical practice.

[16]  P. Schattner,et al.  An Update on the Etiology and Epidemiology of Diabetes Mellitus , 2006, Annals of the New York Academy of Sciences.

[17]  P. Nilsson,et al.  The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003 , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[18]  J. Stengård,et al.  Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland , 1992, Diabetologia.

[19]  Peter Almgren,et al.  Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. , 2005, Diabetes.

[20]  Björn Eliasson,et al.  The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. , 2003, Diabetes care.

[21]  S. Elbein.  Perspective: the search for genes for type 2 diabetes in the post-genome era. , 2002, Endocrinology.

[22]  P. Brennan,et al.  Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? , 2002, Carcinogenesis.

[23]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[24]  D. Easton,et al.  Sibling risks in cancer: clues to recessive or X-linked genes? , 2001, British Journal of Cancer.

[25]  P. Wilson,et al.  Parental transmission of type 2 diabetes: the Framingham Offspring Study. , 2000, Diabetes.

[26]  V. Grill,et al.  Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects , 1999, Diabetologia.

[27]  R. G. Cornell.  Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies , 1992 .

[28]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.